Showing results (351-360 of 500) with videos related to
Sort By:
Pageof 50
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.Neuro-Oncology Practice|September 27, 2019
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalChristopher H Chapman, Jared H Hara, Annette M Molinaro, et al.Lancet (London, England)|September 28, 2011
Inequality in early childhood: risk and protective factors for early child developmentSusan P Walker, Theodore D Wachs, Sally Grantham-McGregor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant gliomaJohn G Kuhn, Susan M Chang, Patrick Y Wen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILEBrian M Alexander, Sujuan Ba, Mitchel S Berger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of GlioblastomaRachael A Vaubel, Shulan Tian, Dioval Remonde, et al.Neuro-Oncology|April 25, 2020
Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatmentRaymond Y Huang, Robert J Young, Benjamin M Ellingson, et al.The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.JCI Insight|November 3, 2018
Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MRSpencer C Behr, Javier E Villanueva-Meyer, Yan Li, et al.Pageof 50